Mechanisms of colorectal liver metastasis development.
Tal ShashaMandy GruijsMarjolein van EgmondPublished in: Cellular and molecular life sciences : CMLS (2022)
Colorectal cancer (CRC) is a leading cause of cancer-related death worldwide, largely due to the development of colorectal liver metastases (CRLM). For the establishment of CRLM, CRC cells must remodel their tumor-microenvironment (TME), avoid the immune system, invade the underlying stroma, survive the hostile environment of the circulation, extravasate into the liver, reprogram the hepatic microenvironment into a permissive pre-metastatic niche, and finally, awake from a dormant state to grow out into clinically detectable CRLM. These steps form part of the invasion-metastasis cascade that relies on reciprocal interactions between the tumor and its ever-changing microenvironment. Such interplay provides a strong rational for therapeutically targeting the TME. In fact, several TME constituents, such as VEGF, TGF-β coreceptor endoglin, and CXCR4, are already targeted in clinical trials. It is, however, of utmost importance to fully understand the complex interactions in the invasion-metastasis cascade to identify novel potential therapeutic targets and prevent the establishment of CRLM, which may ultimately greatly improve patient outcome.
Keyphrases
- liver metastases
- cell migration
- clinical trial
- stem cells
- induced apoptosis
- cancer therapy
- squamous cell carcinoma
- small cell lung cancer
- case report
- endothelial cells
- cell cycle arrest
- randomized controlled trial
- vascular endothelial growth factor
- transforming growth factor
- signaling pathway
- study protocol
- essential oil